Clinical Trial Update: A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of HGS1036 in combination with chemotherapy for advanced solid malignancies has been suspended. The trial status indicates the study is not active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• HGS1036

Snippet

Sponsor: Human Genome Sciences Inc., a GSK Company | Conditions: Cancer | Phase 1 | Status: SUSPENDED